| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Photochem Photobiol] 2023 Mar; Vol. 99 (2), pp. 874-877. <i>Date of Electronic Publication: </i>2022 Oct 06.
- MeSH Terms: Skin Neoplasms* / pathology ; Melanoma* ; Colorectal Neoplasms* / radiotherapy ; Humans ; CD8-Positive T-Lymphocytes / pathology ; Ultraviolet Rays ; Transcription Factors
- References: Lin, M. J., J. Svensson-Arvelund, G. S. Lubitz, A. Marabelle, I. Melero, B. D. Brown and J. D. Brody (2022) Cancer vaccines: The next immunotherapy frontier. Nature cancer 3, 911-926. ; Gabrilovich, D. I., S. Ostrand-Rosenberg and V. Bronte (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268. ; Park, G., Y. H. Cui, S. Yang, M. Sun, E. Wilkinson, H. Li, Y. B. Zhang, J. Chen, M. Bissonnette, W. Lin and Y. Y. He (2022) Moderate low UVB irradiation modulates tumor-associated macrophages and dendritic cells and promotes antitumor immunity in tumor-bearing mice. Photochem. Photobiol. https://doi.org/10.1111/php.13684 (in press). ; Slominski, A. and J. Pawelek (1998) Animals under the sun: Effects of ultraviolet radiation on mammalian skin. Clin. Dermatol. 16, 503-515. ; Didona, D., G. Paolino, U. Bottoni and C. Cantisani (2018) Non melanoma skin cancer pathogenesis overview. Biomedicines 6, 6. ; Yarosh, D. B. (2004) DNA repair, immunosuppression, and skin cancer. Cutis 74, 10-13. ; Strickland, F. M., Y. Sun, A. Darvill, S. Eberhard, M. Pauly and P. Albersheim (2001) Preservation of the delayed-type hypersensitivity response to alloantigen by xyloglucans or oligogalacturonide does not correlate with the capacity to reject ultraviolet-induced skin tumors in mice. J. Invest. Dermatol. 116, 62-68. ; Fell, G. L., K. C. Robinson, J. Mao, C. J. Woolf and D. E. Fisher (2014) Skin β-endorphin mediates addiction to UV light. Cell 157, 1527-1534. ; Rebel, H., C. D. der Spek, D. Salvatori, J. P. van Leeuwen, E. C. Robanus-Maandag and F. R. de Gruijl (2015) UV exposure inhibits intestinal tumor growth and progression to malignancy in intestine-specific Apc mutant mice kept on low vitamin D diet. Int. J. Cancer 136, 271-277. ; Moozhipurath, R. K., L. Kraft and B. Skiera (2020) Evidence of protective role of ultraviolet-B (UVB) radiation in reducing COVID-19 deaths. Sci. Rep. 10, 17705. ; Dunn, G. P., A. T. Bruce, H. Ikeda, L. J. Old and R. D. Schreiber (2002) Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol. 3, 991-998. ; Wu, W., Y. Liu, S. Zeng, Y. Han and H. Shen (2021) Intratumor heterogeneity: The hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes. J. Hematol. Oncol. 14, 160. ; van der Leun, A. M., D. S. Thommen and T. N. Schumacher (2020) CD8(+) T cell states in human cancer: Insights from single-cell analysis. Nat. Rev. Cancer 20, 218-232. ; Yan, Y., L. Huang, Y. Liu, M. Yi, Q. Chu, D. Jiao and K. Wu (2022) Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: Implications for antitumor immunity. J. Hematol. Oncol. 15, 104. ; Ramesh, A., S. Kumar, D. Nandi and A. Kulkarni (2019) CSF1R- and SHP2-inhibitor-loaded nanoparticles enhance cytotoxic activity and phagocytosis in tumor-associated macrophages. Advan. Mat. 31, e1904364. ; Song, Y., L. Bugada, R. Li, H. Hu, L. Zhang, C. Li, H. Yuan, K. K. Rajanayake, N. A. Truchan, F. Wen, W. Gao and D. Sun (2022) Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. Sci. Transl. Med. 14, eabl3649. ; Liu, L., M. A. Lim, S. N. Jung, C. Oh, H. R. Won, Y. L. Jin, Y. Piao, H. J. Kim, J. W. Chang and B. S. Koo (2021) The effect of curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Phytomedicine 92, 153758. ; Beissert, S. and T. Schwarz (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J Investig. Dermatol. Symp. Proceed. 4, 61-64. ; Mantovani, A., F. Marchesi, A. Malesci, L. Laghi and P. Allavena (2017) Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399-416. ; Wculek, S. K., F. J. Cueto, A. M. Mujal, I. Melero, M. F. Krummel and D. Sancho (2020) Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7-24. ; Wang, X., J. Zhang, B. Hu and F. Qian (2022) High expression of CSF-1R predicts poor prognosis and CSF-1R(high) tumor-associated macrophages inhibit anti-tumor immunity in colon adenocarcinoma. Front. Oncol. 12, 850767. ; Candido, J. B., J. P. Morton, P. Bailey, A. D. Campbell, S. A. Karim, T. Jamieson, L. Lapienyte, A. Gopinathan, W. Clark, E. J. McGhee, J. Wang, M. Escorcio-Correia, R. Zollinger, R. Roshani, L. Drew, L. Rishi, R. Arkell, T. R. J. Evans, C. Nixon, D. I. Jodrell, R. W. Wilkinson, A. V. Biankin, S. T. Barry, F. R. Balkwill and O. J. Sansom (2018) CSF1R(+) macrophages sustain pancreatic tumor growth through T cell suppression and maintenance of key gene programs that define the squamous subtype. Cell Rep. 23, 1448-1460. ; Xiao, M., J. He, L. Yin, X. Chen, X. Zu and Y. Shen (2021) Tumor-associated macrophages: Critical players in drug resistance of breast cancer. Front. Immunol. 12, 799428. ; Neesse, A., P. Michl, K. K. Frese, C. Feig, N. Cook, M. A. Jacobetz, M. P. Lolkema, M. Buchholz, K. P. Olive, T. M. Gress and D. A. Tuveson (2011) Stromal biology and therapy in pancreatic cancer. Gut 60, 861-868. ; Beatty, G. L., E. G. Chiorean, M. P. Fishman, B. Saboury, U. R. Teitelbaum, W. Sun, R. D. Huhn, W. Song, D. Li, L. L. Sharp, D. A. Torigian, P. J. O'Dwyer and R. H. Vonderheide (2011) CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science (New York, N.Y.) 331, 1612-1616. ; Bayne, L. J., G. L. Beatty, N. Jhala, C. E. Clark, A. D. Rhim, B. Z. Stanger and R. H. Vonderheide (2012) Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822-835. ; Ye, H., Q. Zhou, S. Zheng, G. Li, Q. Lin, L. Wei, Z. Fu, B. Zhang, Y. Liu, Z. Li and R. Chen (2018) Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Cell Death Dis. 9, 453. ; Mehraj, U., H. Qayoom and M. A. Mir (2021) Prognostic significance and targeting tumor-associated macrophages in cancer: New insights and future perspectives. Breast cancer (Tokyo, Japan) 28, 539-555. ; Xue, T., K. Yan, Y. Cai, J. Sun, Z. Chen, X. Chen and W. Wu (2021) Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer. World J. Surg. Oncol. 19, 186. ; Zhang, Q. W., L. Liu, C. Y. Gong, H. S. Shi, Y. H. Zeng, X. Z. Wang, Y. W. Zhao and Y. Q. Wei (2012) Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. PloS one 7, e50946. ; Joyce, J. A. and J. W. Pollard (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252. ; Eisel, D., K. Das, E. Dickes, R. König, W. Osen and S. B. Eichmüller (2019) Cognate interaction with CD4(+) T cells instructs tumor-associated macrophages to acquire M1-like phenotype. Front. Immunol. 10, 219. ; Panni, R. Z., J. M. Herndon, C. Zuo, S. Hegde, G. D. Hogg, B. L. Knolhoff, M. A. Breden, X. Li, V. E. Krisnawan, S. Q. Khan, J. K. Schwarz, B. E. Rogers, R. C. Fields, W. G. Hawkins, V. Gupta and D. G. DeNardo (2019) Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Sci. Transl. Med. 11, eaau9240. ; Ngambenjawong, C., H. H. Gustafson and S. H. Pun (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv. Drug Deliv. Rev. 114, 206-221. ; Mantovani, A., S. Sozzani, M. Locati, P. Allavena and A. Sica (2002) Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555. ; Casares, N., M. O. Pequignot, A. Tesniere, F. Ghiringhelli, S. Roux, N. Chaput, E. Schmitt, A. Hamai, S. Hervas-Stubbs, M. Obeid, F. Coutant, D. Métivier, E. Pichard, P. Aucouturier, G. Pierron, C. Garrido, L. Zitvogel and G. Kroemer (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202, 1691-1701. ; Galluzzi, L., A. Buqué, O. Kepp, L. Zitvogel and G. Kroemer (2017) Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97-111. ; Merad, M., P. Sathe, J. Helft, J. Miller and A. Mortha (2013) The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604. ; Mildner, A. and S. Jung (2014) Development and function of dendritic cell subsets. Immunity 40, 642-656. ; Mashayekhi, M., M. M. Sandau, I. R. Dunay, E. M. Frickel, A. Khan, R. S. Goldszmid, A. Sher, H. L. Ploegh, T. L. Murphy, L. D. Sibley and K. M. Murphy (2011) CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by toxoplasma gondii tachyzoites. Immunity 35, 249-259.
- Substance Nomenclature: 0 (Transcription Factors)
- Entry Date(s): Date Created: 20220924 Date Completed: 20230331 Latest Revision: 20230502
- Update Code: 20231215
|
